Trial intelligence / Profile preview

Lacosamide Extension Study in Asian Adults with Partial-onset Seizures

NCT01832038Phase 3Completed

Sponsor
UCB
Start
Mar 2013
Primary completion
Jul 2019
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of lacosamide in focal onset seizure, sponsored by UCB. Started Mar 2013; status: completed.

02

Drugs

lacosamide
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT01832038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01832038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call